human leukocyte antigen

human leukocyte antigen
Name	Human leukocyte antigen
System	Immune system

human leukocyte antigen The human leukocyte antigen complex is a polymorphic set of cell-surface proteins encoded in the major histocompatibility complex region on chromosome 6 that mediates peptide presentation to T lymphocytes and influences transplant compatibility and autoimmune risk. Prominent in immunology, hematology, and transplantation medicine, it has been studied by institutions such as the National Institutes of Health, Cleveland Clinic, Mayo Clinic, and researchers affiliated with Oxford University, Harvard University, Stanford University and the Karolinska Institute. Breakthroughs involving HLA have been reported in journals like Nature, Science, The Lancet, and New England Journal of Medicine and have shaped guidelines from bodies including the World Health Organization and the European Society for Blood and Marrow Transplantation.

Overview

The HLA complex resides within the major histocompatibility complex on human chromosome 6 and comprises class I, class II, and class III regions described in mapping studies by teams at Cold Spring Harbor Laboratory, Max Planck Society, Wellcome Trust Sanger Institute, and European Bioinformatics Institute. Early foundational work linking HLA to tissue transplantation and disease associations involved investigators at Johns Hopkins Hospital, Fred Hutchinson Cancer Center, and laboratories led by scientists such as Jean Dausset, Baruj Benacerraf, and Peter Medawar, who together influenced Nobel-recognized advances in immunology. The clinical importance of HLA spans hematopoietic stem cell transplantation protocols developed at Seattle Cancer Care Alliance and organ allocation policies used by United Network for Organ Sharing and Eurotransplant.

Genetic organization and nomenclature

The HLA region includes gene clusters designated HLA-A, HLA-B, and HLA-C in class I and HLA-DP, HLA-DQ, and HLA-DR in class II; landmark allele cataloging has been carried out by the World Health Organization Nomenclature Committee and databases maintained at the European Bioinformatics Institute and National Center for Biotechnology Information. High-resolution typing techniques using next-generation sequencing and platforms from companies like Illumina, Thermo Fisher Scientific, and academic consortia such as the 1000 Genomes Project and the Human Genome Project enabled allele frequency surveys across cohorts from the HapMap Project, International HapMap Consortium, and population studies led by institutions in Japan, Nigeria, Brazil, India, and Sweden. Standardized allele naming conventions were promulgated at meetings involving representatives from American Society for Histocompatibility and Immunogenetics, European Federation for Immunogenetics, and the World Marrow Donor Association.

Structure and function

Class I HLA molecules (HLA-A, HLA-B, HLA-C) consist of a heavy chain and beta-2 microglobulin and present endogenous peptides to CD8+ T cells; structural elucidation was advanced by crystallography groups at MRC Laboratory of Molecular Biology, Institute Pasteur, and labs collaborating with Howard Hughes Medical Institute. Class II molecules (HLA-DR, HLA-DQ, HLA-DP) present exogenous peptides to CD4+ T cells, with antigen-processing pathways characterized in studies from Rockefeller University, Yale School of Medicine, and Massachusetts General Hospital. Structural studies informed vaccine design efforts led by teams at Imperial College London, Johns Hopkins Bloomberg School of Public Health, and Scripps Research Institute, while peptide-binding prediction algorithms were developed in groups associated with European Molecular Biology Laboratory and Carnegie Mellon University.

Role in immunity and disease association

HLA allele variation influences susceptibility and resistance to infectious diseases studied at Centers for Disease Control and Prevention, Pasteur Institute, and The Alfred Hospital, including associations with viral infections investigated during outbreaks by World Health Organization, Centers for Disease Control and Prevention, and research networks at Emory University and University of Cape Town. Strong HLA associations have been documented for autoimmune conditions such as ankylosing spondylitis (linked to HLA-B27), type 1 diabetes (HLA-DR and HLA-DQ), narcolepsy (HLA-DQB1*06:02), and celiac disease (HLA-DQ2/DQ8) in cohort studies conducted by teams at Karolinska Institute, University of Cambridge, University of Oxford, and Mayo Clinic. HLA alleles also modulate drug hypersensitivity reactions exemplified by HLA-B*57:01 and abacavir hypersensitivity identified in clinical research at St. Vincent's Hospital and pharmacogenetics consortia including CPIC and FDA-linked programs.

Clinical applications and transplantation

HLA matching is central to kidney, liver, heart, and hematopoietic stem cell transplantation programs operated by United Network for Organ Sharing, Eurotransplant, Australian and New Zealand Dialysis and Transplant Registry, and transplant centers at Cleveland Clinic, Johns Hopkins Hospital, and Mayo Clinic. Donor registries such as Be The Match (operated by the National Marrow Donor Program) and Bone Marrow Donors Worldwide rely on high-resolution HLA typing standards from American Society for Histocompatibility and Immunogenetics and support outcomes research published in The Lancet Haematology and Blood. Clinical strategies including desensitization, crossmatch testing, and post-transplant immunosuppression were developed through randomized trials at institutions like Massachusetts General Hospital and multicenter collaborations funded by agencies such as the National Institutes of Health and the European Commission.

Population variation and evolutionary aspects

Extensive HLA diversity across human populations has been characterized by anthropological and genetic studies involving teams at University of California, Berkeley, Stanford University, Max Planck Institute for Evolutionary Anthropology, and the Wellcome Sanger Institute, revealing signals of balancing selection, local adaptation to pathogens, and admixture in populations from Africa, Europe, Asia, Americas, and Oceania. Evolutionary analyses leveraging data from the 1000 Genomes Project, ancient DNA studies by groups at University of Copenhagen and University of Cambridge, and pathogen-focused consortia like the MalariaGEN network have linked HLA allele frequencies to historic selective pressures including malaria, tuberculosis, and viral pandemics tracked by World Health Organization surveillance. Population-specific HLA reference panels inform donor matching efforts by the World Marrow Donor Association and national registries such as Be The Match.

Category:Immunology